Concepedia

Publication | Closed Access

Dietary Fe<sub>3</sub>O<sub>4</sub>Nanozymes Prevent the Injury of Neurons and Blood–Brain Barrier Integrity from Cerebral Ischemic Stroke

62

Citations

41

References

2020

Year

Abstract

Cerebral ischemic stroke stimulates excessive reactive oxygen species, which lead to blood-brain-barrier disruption, neuron death, and aggravated cerebral infarction. Thus, it is critical to develop an antioxidant strategy for stroke treatment. Herein, we report a dietary strategy to promote stroke healing using iron oxide (Fe<sub>3</sub>O<sub>4</sub>) nanoparticles with intrinsic enzyme-like activities. We find that Fe<sub>3</sub>O<sub>4</sub> nanozymes exhibit triple enzyme-like activities, peroxidase, catalase, and superoxide dismutase, thus potentially possessing the ability to regulate the ROS level. Importantly, intragastric administration of PEG-modified Fe<sub>3</sub>O<sub>4</sub> nanozymes significantly reduces cerebral infarction and neuronal death in a rodent model following cerebral ischemic stroke. <i>Ex vivo</i> analysis shows that PEG-modified Fe<sub>3</sub>O<sub>4</sub> nanozymes localize in the cerebral vasculature, ameliorate local redox state with decreased malondialdehyde and increased Cu/Zn SOD, and facilitate blood-brain-barrier recovery by elevating ZO-1 and Claudin-5 in the hippocampus. Altogether, our results suggest that dietary PEG-modified Fe<sub>3</sub>O<sub>4</sub> nanozymes can facilitate blood-brain-barrier reconstruction and protect neurons following ischemic stroke.

References

YearCitations

Page 1